Petmed Express (PETS) Cash & Equivalents (2010 - 2026)

Petmed Express' Cash & Equivalents history runs 16 years deep, the most recent figure standing at $26.9 million for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 46.28% year-over-year to $26.9 million; the TTM figure through Dec 2025 stood at $26.9 million (down 46.28% YoY), while the FY2025 annual figure was $54.7 million, down 1.04% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $26.9 million, down from $36.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $118.7 million in Q1 2021, with the low at $26.9 million in Q4 2025.
• The 5-year median for Cash & Equivalents is $58.4 million (2023), against an average of $74.6 million.
• The sharpest annual moves came in 2021 and 2023: Cash & Equivalents advanced 28.75% in 2021, then plunged 51.77% in 2023.
• Petmed Express' Cash & Equivalents stood at $108.9 million in 2021, then decreased by 5.95% to $102.4 million in 2022, then slumped by 51.77% to $49.4 million in 2023, then advanced by 1.42% to $50.1 million in 2024, then slumped by 46.28% to $26.9 million in 2025.
• Business Quant data shows PETS's Cash & Equivalents at $26.9 million in Q4 2025, $36.1 million in Q3 2025, and $41.1 million in Q2 2025.